lobbying_activities: 1691848
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1691848 | 643809be-0b29-4a4a-aae4-75df72146a75 | Q2 | DALRYMPLE & ASSOCIATES, LLC | 5073 | EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) | 2015 | second_quarter | HOM | Advocating the availability of FDA approved medical countermeasures for the protection of emergency responders against CBRN threats on a voluntary basis under appropriate medical supervision | Centers For Disease Control & Prevention (CDC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Defense Logistics Agency,Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Joint Chiefs of Staff,Natl Institutes of Health (NIH),SENATE,White House Office | 46000 | 0 | 0 | 2015-07-09T09:59:52.540000-04:00 |